Braftovi outdoes Tafinlar in colorectal cancer
US approval gives Pfizer the first and second-line settings.
FDA red and green lights: November 2024
Autolous, Syndax, Jazz and Shorla get US approvals in a quiet month.
US approval gives Pfizer the first and second-line settings.
Autolous, Syndax, Jazz and Shorla get US approvals in a quiet month.
